Should Aspirin Be Prescribed to Prevent Recurrence in Nonarteritic Anterior Ischemic Optic Neuropathy

Update item information
Title Should Aspirin Be Prescribed to Prevent Recurrence in Nonarteritic Anterior Ischemic Optic Neuropathy
Creator Robert A. Egan, Anthony C. Arnold, Andrew G. Lee, Gregory P. Van Stavern
Affiliation MultiCare Rockwood Clinic (RE), Spokane, Washington; Department of Ophthalmology (ACA), Jules Stein Eye Institute, University of California Los Angeles, Los Angeles, California; Blanton Eye Institute (AGL), Houston Methodist Hospital, Houston, Texas; and Department of Ophthalmology and Visual Sciences (GVS), Washington University in St. Louis, St. Louis, Missouri
Abstract Nonarteritic anterior ischemic optic neuropathy (NAION) has no proven treatment and typically causes some degree of irreversible visual loss. Preventing second eye involvement is a worthy goal, but there is uncertainty regarding the benefit of any preventive therapy. Two experts debate the role of aspirin in preventing fellow eye involvement in NAION.
OCR Text Show
Publisher Lippincott, Williams & Wilkins
Date 2020-09
Type Text
Source Journal of Neuro-Ophthalmology, September 2020, Volume 40, Issue 3
Language eng
Rights Management © North American Neuro-Ophthalmology Society
Publication Type Journal Article
ARK ark:/87278/s6gj57f0
Setname ehsl_novel_jno
Date Created 2020-09-15
Date Modified 2021-05-06
ID 1592985
Reference URL https://collections.lib.utah.edu/ark:/87278/s6gj57f0